Covid-19: Surplus Vaccine Doses

Lord Lansley Excerpts

Monday 22nd February 2021 Lords Chamber

[Lord Ahmad of Wimbledon (Con)]

My Lords, I have already said where we are on ODA. As ever, I make note of the strong sentiments in your Lordships’ House.

[Lord Lansley (Con) [V]]

My Lords, I join in applauding the Government’s leadership in its support for the COVAX facility, but does the Minister recognise that only today the World Health Organization’s director-general expressed concern that COVAX is having problems trying to source early supply of vaccine, while at the same time some of the richest countries in the world continue to contract for early delivery of vaccine? We need to take an initiative to enable the rich countries to secure early vaccine supply to COVAX. I wonder if the Government can use their leadership in COVAX to secure that kind of initiative.

[Lord Ahmad of Wimbledon (Con)]

My Lords, I hear my noble friend, who speaks with great experience of the health sector. As he is aware, COVAX is explicitly designed to work for high-income, low-income and middle-income countries. That is why the Government led the AMC facility to ensure equitable access to the 92 most vulnerable countries. We continue to collaborate with other key partners through our influence at the World Health Organization, GAVI and CEPI to ensure that the COVAX AMC facility is fully supported by all.